Verification Result Regarding Interventional Brain-Computer Interface Clinical Progress of Wanma Co., Ltd.
Unlock More Features
Login to access AI-powered analysis, deep research reports and more advanced features
About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.
Related Stocks
After comprehensive search and verification of public information,
Wanma Co., Ltd. (Zhejiang Wanma Co., Ltd.) is an electrical equipment manufacturer mainly engaged in businesses such as wire and cable, polymer materials, and electrical equipment[0]. According to the company profile, its industry is categorized as “Industry | Electrical Equipment and Components”, and it does not operate in the medical health or neurotechnology fields[0].
Through searching clinical progress in the brain-computer interface industry, it is found that the institutions clearly conducting interventional brain-computer interface clinical trials currently include:
- Sanbo Brain Hospital: Participated in and completed the world’s first interventional brain-computer interface-assisted motor function restoration trial for human affected limbs in June 2025[1]
- Professor Duan Feng’s Team from Nankai University: Led the world’s first interventional brain-computer interface human trial, using a minimally invasive interventional approach to introduce stent electrodes into the intracranial vascular wall via vascular puncture[2]
- Brain Tiger Technology: Had completed 54 cases of brain-computer interface human implantations by the end of 2025[3]
- Sinoway Medical: Cooperated with Nankai University to develop interventional brain-computer interface products[4]
In brain-computer interface industry research reports, the involved companies include Borui Kang, Xinzhida, Brain Tiger Technology, Jieti Medical, and other enterprises focusing on brain-computer interface technology R&D, as well as medical enterprises participating in clinical applications such as Sanbo Brain Hospital and Sinoway Medical, but
Based on existing public information, as an electrical equipment manufacturer,
[0] Jinling API - Company Profile and Financial Data of Wanma Co., Ltd. (002276.SZ)
[1] Securities Times Network - “After Successful Clinical Trials, Brain-Computer Interfaces Begin to Address Commercialization Issues” (https://www.stcn.com/article/detail/3546315.html)
[2] Sina Finance - “How Advanced is China’s Brain-Computer Interface Technology?” (https://finance.sina.com.cn/stock/t/2026-01-09/doc-inhfsfzz0681393.shtml)
[3] Sina Finance - “In-Depth | Brain-Computer Interface ‘Boom’: Musk Launches Large-Scale Mass Production” (https://finance.sina.com.cn/stock/t/2026-01-03/doc-inhezqrp3616265.shtml)
[4] Eastmoney.com - Industry Report “Three Dimensions to View the Development Trend of the Brain-Computer Interface Industry” (https://pdf.dfcfw.com/pdf/H301_AP202511061776241998_1.pdf)
Insights are generated using AI models and historical data for informational purposes only. They do not constitute investment advice or recommendations. Past performance is not indicative of future results.
About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.
